Morgan Stanley raises target for Amplifon stock to EUR 14.96

Published on 10/19/2026 at 09:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Morgan Stanley kept Overweight and lifted its target to EUR 14.96 on October 9, 2026. Amplifon stock costs EUR 12.52 on October 19, 2026, below target.

Analyst target and reporting date

Morgan Stanley set a EUR 14.96 target on October 9, 2026.
First-half 2026 revenue reached EUR 1.19 billion, up 1.30 percent at constant exchange rates.
Amplifon stock was trading at EUR 12.52 at 9:46 a.m. CEST at Lang & Schwarz on October 19, 2026.

Isometrische 3D-Illustration einer Wertschöpfungskette von Diagnose bis Verkauf — Isometrische 3D-Grafik der Wertschöpfungskette veranschaulicht Geschäftsmodell von Amplifon S.p.A., ISIN IT0004056880, im Gesundheitssektor, Illustration mit AI erstellt.

Amplifon (ISIN IT0004056880) was trading at EUR 12.52 at Lang & Schwarz on October 19, 2026 at 9:46 a.m. CEST. The latest analyst catalyst came on October 9, when Morgan Stanley kept its Overweight rating and raised its target to EUR 14.96 from EUR 14.90, as reported by Teleborsa.

Operating growth supports the case

Amplifon's first-half 2026 revenue reached EUR 1.19 billion, up 1.30 percent at constant exchange rates, while organic growth reached 3.50 percent, according to Capital.com. Adjusted EBITDA rose 3.60 percent to EUR 298.00 million, and the adjusted EBITDA margin increased to 25.10 percent from the prior-year period.

The second quarter supplied the stronger operating signal. Organic growth reached 4.70 percent, while the adjusted EBITDA margin reached 25.80 percent. Management also retained its full-year objective for organic growth above 3.00 percent and an adjusted EBITDA margin improvement of about 100 basis points, as described in the same results coverage.

Three milestones set the backdrop

On March 16, 2026, Amplifon announced the EUR 2.30 billion acquisition of GN Hearing, including 56 million new Amplifon shares, according to Rankia. On May 22, the company placed 45.30 million new shares at EUR 10.00, raising EUR 453.00 million. On October 9, Morgan Stanley lifted its target from EUR 14.90 to EUR 14.96 while retaining Overweight, according to Teleborsa.

What dates matter next?

Amplifon is scheduled to publish its third-quarter and nine-month 2026 results on October 29, 2026. The company also called a shareholders meeting for the same date, including resolutions connected with the GN Hearing transaction, according to Amplifon. That combination puts operating delivery and transaction execution on the same timetable.

Price stays below the analyst target

The EUR 14.96 Morgan Stanley target stands EUR 2.44 above the Lang & Schwarz price of EUR 12.52. The gap leaves the October 29 results as the next concrete test for growth, margins and the proposed GN Hearing integration.

The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.